GlassScriptPhysician profile
Robert L Nichols
NPI 1679634562
$640.48
in general payments reported to CMS, 2019-2025
11 companies · $352 in 2025
The $352 reported for 2025 was more than what 78% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.04 · 2020: $26.92 · 2021: $14.46 · 2022: $24.44 · 2023: $32.85 · 2024: $159 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.62 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $244.90 | 2024-2025 | Dexcom G6 Transmitter |
| Jazz Pharmaceuticals INC. | $150.00 | 2025 | |
| Abbvie INC. | $76.96 | 2021-2025 | |
| Mannkind Corporation | $31.04 | 2024 | |
| Pfizer INC. | $24.74 | 2024 | |
| Abbott Laboratories | $24.44 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.24 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $17.65 | 2019 | |
| Glaxosmithkline, LLC. | $16.50 | 2023 | Shingrix, Arexvy |
| Lilly USA, LLC | $15.07 | 2020 | |
| Exact Sciences Corporation | $14.94 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.